American International Group’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-13,000
| Closed | -$145K | – | 127 |
|
|
2024
Q1 | $145K | Sell |
13,000
-398
| -3% | -$4.44K | ﹤0.01% | 2319 |
|
|
2023
Q4 | $199K | Buy |
13,398
+2,600
| +24% | +$38.7K | ﹤0.01% | 2171 |
|
|
2023
Q3 | $51.8K | Buy |
10,798
+385
| +4% | +$1.85K | ﹤0.01% | 2806 |
|
|
2023
Q2 | $78.2K | Buy |
10,413
+60
| +0.6% | +$451 | ﹤0.01% | 2720 |
|
|
2023
Q1 | $46.8K | Buy |
10,353
+206
| +2% | +$931 | ﹤0.01% | 2736 |
|
|
2022
Q4 | $114K | Sell |
10,147
-37
| -0.4% | -$417 | ﹤0.01% | 2442 |
|
|
2022
Q3 | $97K | Buy |
10,184
+144
| +1% | +$1.37K | ﹤0.01% | 2573 |
|
|
2022
Q2 | $81K | Buy |
10,040
+1,237
| +14% | +$9.98K | ﹤0.01% | 2704 |
|
|
2022
Q1 | $149K | Sell |
8,803
-619
| -7% | -$10.5K | ﹤0.01% | 2417 |
|
|
2021
Q4 | $202K | Sell |
9,422
-283
| -3% | -$6.07K | ﹤0.01% | 2365 |
|
|
2021
Q3 | $717K | Sell |
9,705
-230
| -2% | -$17K | ﹤0.01% | 1625 |
|
|
2021
Q2 | $543 | Sell |
9,935
-233
| -2% | -$13 | ﹤0.01% | 1869 |
|
|
2021
Q1 | $750 | Buy |
10,168
+4,508
| +80% | +$333 | ﹤0.01% | 1621 |
|
|
2020
Q4 | $488 | Sell |
5,660
-64
| -1% | -$6 | ﹤0.01% | 1758 |
|
|
2020
Q3 | $216K | Buy |
+5,724
| New | +$216K | ﹤0.01% | 2099 |
|